GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (XCNQ:MPXI) » Definitions » EV-to-EBITDA

MPX International (XCNQ:MPXI) EV-to-EBITDA : -1.89 (As of Jun. 02, 2024)


View and export this data going back to 2019. Start your Free Trial

What is MPX International EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MPX International's enterprise value is C$25.08 Mil. MPX International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 was C$-13.28 Mil. Therefore, MPX International's EV-to-EBITDA for today is -1.89.

The historical rank and industry rank for MPX International's EV-to-EBITDA or its related term are showing as below:

XCNQ:MPXI's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.36
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-02), MPX International's stock price is C$0.005. MPX International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was C$-0.180. Therefore, MPX International's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


MPX International EV-to-EBITDA Historical Data

The historical data trend for MPX International's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International EV-to-EBITDA Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
EV-to-EBITDA
- -7.97 -0.66 -1.79

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -0.86 -1.79 -1.53 -2.38

Competitive Comparison of MPX International's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPX International's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MPX International's EV-to-EBITDA falls into.



MPX International EV-to-EBITDA Calculation

MPX International's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=25.077/-13.284
=-1.89

MPX International's current Enterprise Value is C$25.08 Mil.
MPX International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-13.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MPX International  (XCNQ:MPXI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MPX International's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.005/-0.180
=At Loss

MPX International's share price for today is C$0.005.
MPX International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


MPX International EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MPX International's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


MPX International (XCNQ:MPXI) Business Description

Traded in Other Exchanges
N/A
Address
5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.
Executives
William Scott Boyes Director, Senior Officer
Randall Glenn Stafford Director

MPX International (XCNQ:MPXI) Headlines

No Headlines